UBS raised the firm’s price target on Qualys (QLYS) to $150 from $145 and keeps a Neutral rating on the shares. Qualys’ Q3 was another positive step, featuring the third consecutive quarter of revenue growth acceleration and meaningful margin upside, though this was paired with a somewhat more mixed outlook for Q4, the analyst tells investors in a research note. The company seems more confident that execution around its ETM and ROC products is improving, but still sounds mixed on new logo growth and NRR is still hovering in the low-single-digit range, the firm says.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLYS:
- Balanced Outlook on Qualys: Growth Amid Uncertainties Leads to Hold Rating
- Qualys: Sustained Revenue Growth Amid Mixed Outlook and Valuation Concerns
- Qualys upgraded to Neutral from Underweight at Piper Sandler
- Balanced Outlook on Qualys: Strong Performance Amid Risks Justifies Hold Rating
- Qualys: Strong Q3 2025 Results Amid Competitive Challenges Justify Hold Rating